Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
신규 편입 · 포트폴리오 비중 0.05%
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
What Is Roivant Sciences (ROIV) Signaling With Its Positive PH ILD Trial Data?
Director Melissa Epperly Sells 4,938 Shares of Roivant Sciences Ltd (ROIV) - GuruFocus
Director Melissa Epperly Sells 4,938 Shares of Roivant Sciences Ltd (ROIV) GuruFocus
Roivant Sciences (NASDAQ: ROIV) director sells 4,938 shares under 10b5-1 plan - Stock Titan
Roivant Sciences (NASDAQ: ROIV) director sells 4,938 shares under 10b5-1 plan Stock Titan
Roivant Sciences (ROIV) director sells 5,112 shares under pre-set plan - Stock Titan
Roivant Sciences (ROIV) director sells 5,112 shares under pre-set plan Stock Titan
Roivant Sciences Price Target Announced at $51.00/Share by Stifel - Moomoo
Roivant Sciences Price Target Announced at $51.00/Share by Stifel Moomoo
JPMorgan reiterates Roivant Sciences stock rating on survey data - Investing.com
JPMorgan reiterates Roivant Sciences stock rating on survey data Investing.com
No earnings data to show.
No research actions to show.
Price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 890,900 | $24.68M | 0.04% | — | New position |
| 2 | SOROS FUND MANAGEMENT LLC | SOROS FUND MANAGEMENT LLC | 9,492 | $205.98K | 0.00% | — | New position |
